Microbion Corporation   Report issue

For profit Phase 2
Founded: Bozeman MT United States (1982)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2016
NCT02436876
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Microbion Corporation

Active Ingredients

Drugs in Phase 2 Trials (1)

pravibismane (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 2)

Diabetic Foot (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1